Crossmark

Commentary in reply to a publication on Plasmodium falciparum pre-erythrocytic stage vaccine development

Published Online: 2020-07-20

Published Print: 2020-12

Authors

Roman, François P.

Coccia, Margherita

Schuerman, Lode
Funding

Funding for this research was provided by:

GlaxoSmithKline foundation
License Information

Text and Data Mining valid from 2020-07-20

Version of Record valid from 2020-07-20
More Information

Article History

Received: 25 May 2020

Accepted: 13 July 2020

First Online: 20 July 2020

Ethics approval and consent to participate

: As the present manuscript (Commentary) is not a clinical study, there was no need neither for ethics committee approval nor for informed consent to participate.

: No details on individuals are reported within the manuscript, therefore consent for publication of images is not applicable.

: François P. Roman, Margherita Coccia and Lode Schuerman are employees of the GSK group of companies hold shares in the GSK group of companies, have full access to the data included in the current work and have final responsibility for the decision to submit for publication.

Document is current